ZRC has constituted a Scientific Advisory Board comprising of world renowned scientists and clinicians to advice the group in its research endeavors.
Dr. John Amatruda
Most recently Dr. Amatruda was Senior Vice President and Franchise Head for Diabetes and Obesity and a member of the Research Management Committee at Merck. Dr Amatruda graduated from Yale University, received his MD degree from the Medical College of Wisconsin and did his internship and residency in Internal Medicine and Fellowship in Endocrinology and Metabolism at The Johns Hopkins Hospital. He is board certified in internal medicine and Endocrinology and Metabolism. ( For more details,click here)
Dr. Kapil Dhingra
Kapil Dhingra has served as a member of Micromet’s Board of Directors since February 2009. In June 2008, Dr. Dhingra founded KAPital Consulting, LLC, a healthcare consulting firm. From 1999 to 2008, Dr. Dhingra served in positions of increasing responsibility at Hoffmann-La Roche, including Vice President, Head, Oncology Disease Biology Leadership Team, and Head, Oncology Clinical Development. Prior to joining Hoffmann-La Roche, Dr. Dhingra worked as a Senior Clinical Research Physician with Eli Lilly and Company. . ( For more details,click here)
Prof. Dr. Rolf Werner
Prof. Werner is worldwide well respected for his seminal contributions to biotechnology during his tenure at Boehringer Ingelheim as well as at the Universities of Tuebingen and Chiang Mai for more than 40 years.( For more details,click here)
Dr. Robert R. Henry
Dr. Henry is an internationally renowned clinical investigator and scientist. Dr. Henry is Professor of Medicine at the University of California San Diego and the Chief of Endocrinology at the VA San Diego Healthcare System. ( For more details,click here)
Dr. Charles F. Burant, MD, PhD
Dr. Charles F. Burant, MD, PhD is Professor of Internal Medicine at the University of Michigan Health System in Ann Arbor, Michigan. He currently is the Robert C. and Veronica Atkins Professor of Metabolism and directs the Michigan Metabolomics and Obesity Center. His research interests are in the areas of the molecular and cellular biology of insulin resistance and the effect of insulin resistance on ß-cell function as well as lipid and glucose metabolism. His clinical interests are focused on type 2 diabetes, insulin resistance, and the metabolic syndrome. Dr Burant is an Associate Editor for the American Journal of Physiology-Endocrinology and Metabolism. He is active in the American Diabetes Association, serving on the Research Policy Committee and the Board of Directors of the Research Foundation.
( For more details,click here)
Suad Efendic, MD, PhD, Professor
Suad Efendic is a Professor of Endocrinology at Karolinska Institutet, Adjunct Professor of Physiology at the University of Toronto, and Professor of Medicine at the University of Zagreb. Since 1991 he has been a member of the Nobel prize Assembly. From 1988-1995 he was the Head of the Department of Endocrinology and Diabetology at Karolinska Hospital. ( For more details,click here)
Dr. Lee S. Simon
Dr. Simon is currently an Associate Clinical Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center (BIDMC) in Boston, MA, USA. Previously, he was Director of Rheumatology Clinical Research, an Associate Chief of Medicine, and Director of Graduate Medical Education at BIDMC. ( For more details,click here)
In addition to the Scientific Advisory Board, ZRC also has well-experienced advisors to help the research team in making appropriate decisions on various targets and research areas of focus to the company.
